Shorepoint Capital Partners LLC Bristol Myers Squibb CO Transaction History

Shorepoint Capital Partners LLC

$416 Million
Q2 2024

A detailed history of Shorepoint Capital Partners LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Shorepoint Capital Partners LLC holds 85,675 shares of BMY stock, worth $4.51 Million. This represents 0.85% of its overall portfolio holdings.

Number of Shares

85,675

Previous 94,428 9.27%

Holding current value

$4.51 Million

Previous $5.12 Million 30.51%

% of portfolio

0.85%

Previous 1.25%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	SELL	$40.25 - $52.99 $352,308 - $463,821	-8,753 Reduced 9.27%	85,675 $3.56 Million
Q1 2024 May 14, 2024	BUY	$47.98 - $54.4 $133,768 - $151,667	2,788 Added 3.04%	94,428 $5.12 Million
Q4 2023 Feb 13, 2024	BUY	$48.48 - $57.85 $283,559 - $338,364	5,849 Added 6.82%	91,640 $4.7 Million
Q3 2023 Nov 14, 2023	BUY	$57.89 - $64.73 $235,901 - $263,774	4,075 Added 4.99%	85,791 $4.98 Million
Q2 2023 Aug 14, 2023	BUY	$63.71 - $70.74 $52,815 - $58,643	829 Added 1.02%	81,716 $5.23 Million
Q1 2023 May 15, 2023	SELL	$65.71 - $74.53 $243,455 - $276,133	-3,705 Reduced 4.38%	80,887 $5.61 Million
Q4 2022 Feb 14, 2023	BUY	$68.48 - $81.09 $73,684 - $87,252	1,076 Added 1.29%	84,592 $6.09 Million
Q3 2022 Nov 14, 2022	BUY	$0.13 - $76.84 $188 - $111,648	1,453 Added 1.77%	83,516 $5.94 Million
Q2 2022 Aug 15, 2022	SELL	$72.62 - $79.98 $310,305 - $341,754	-4,273 Reduced 4.95%	82,063 $6.32 Million
Q1 2022 May 09, 2022	SELL	$61.48 - $73.72 $57,237 - $68,633	-931 Reduced 1.07%	86,336 $6.31 Million
Q4 2021 Feb 14, 2022	BUY	$53.63 - $62.52 $172,045 - $200,564	3,208 Added 3.82%	87,267 $5.44 Million
Q3 2021 Nov 05, 2021	BUY	$59.17 - $69.31 $769,683 - $901,584	13,008 Added 18.31%	84,059 $4.97 Million
Q1 2021 May 10, 2021	BUY	$59.34 - $66.74 $361,914 - $407,047	6,099 Added 9.39%	71,051 $4.49 Million
Q4 2020 Feb 16, 2021	BUY	$57.74 - $65.43 $144,580 - $163,836	2,504 Added 4.01%	64,952 $4.03 Million
Q3 2020 Nov 16, 2020	BUY	$57.43 - $63.64 $421,478 - $467,053	7,339 Added 13.32%	62,448 $3.77 Million
Q2 2020 Aug 12, 2020	BUY	$54.82 - $64.09 $1.18 Million - $1.38 Million	21,499 Added 63.97%	55,109 $3.24 Million
Q1 2020 May 14, 2020	BUY	$46.4 - $67.43 $1.56 Million - $2.27 Million	33,610 New	33,610 $1.87 Million

Others Institutions Holding BMY

# of Institutions

2,438

Shares Held

1.51B

Call Options Held

29.7M

Put Options Held

32.1M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $112B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Shorepoint Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Shorepoint Capital Partners LLC with notifications on news.

Account

Shorepoint Capital Partners LLC Bristol Myers Squibb CO Transaction History